Study suggests a protein may predict severe COVID-19
Companies, agencies, institutions, etc
COVID-19.The
Critical Care
the Ralph C. Brown
Internal Medicine
the Department of Internal Medicine at Rush University
home.”“Plasma
the Rush University Medical Center
the University of Athens Medical School
patients’
BMJ
People
Jochen Reiser
Jochen ReiserThe
Groups
COVID-19
Physical locations
No matching tags
Places
No matching tags
Locations
MD
Chicago
Greece
COVID-19.For
Events
No matching tags
Summary
High levels of the protein suPAR in the blood of a person with COVID-19 may be a predictor of a more severe disease course.A new study suggests that the protein soluble urokinase plasminogen activator receptor (suPAR) may help scientists predict who is likely to develop more severe COVID-19.The research, published as a research letter in the journal Critical Care, may help clinicians identify people who are more likely to need intensive care support.
As said here by https://www.medicalnewstoday.com/articles/study-suggests-a-protein-may-predict-severe-covid-19